Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Share-based Compensation (2020 - 2025)

Rapid Micro Biosystems' Share-based Compensation history spans 6 years, with the latest figure at $1.1 million for Q3 2025.

  • For Q3 2025, Share-based Compensation rose 23.36% year-over-year to $1.1 million; the TTM value through Sep 2025 reached $4.1 million, down 2.66%, while the annual FY2024 figure was $3.9 million, 18.44% down from the prior year.
  • Share-based Compensation for Q3 2025 was $1.1 million at Rapid Micro Biosystems, down from $1.2 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $1.3 million in Q2 2022 and bottomed at $191000.0 in Q1 2021.
  • The 5-year median for Share-based Compensation is $1.0 million (2025), against an average of $941684.2.
  • The largest annual shift saw Share-based Compensation surged 414.66% in 2022 before it plummeted 32.58% in 2024.
  • A 5-year view of Share-based Compensation shows it stood at $678000.0 in 2021, then surged by 62.98% to $1.1 million in 2022, then dropped by 7.51% to $1.0 million in 2023, then tumbled by 32.58% to $689000.0 in 2024, then skyrocketed by 66.33% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for RPID's Share-based Compensation are $1.1 million (Q3 2025), $1.2 million (Q2 2025), and $1.0 million (Q1 2025).